Study Design

Premier Voices #1: Rare Oncology w/ Colin Hayward & Peter Larson

The inaugural edition of Premier Voices focuses on rare oncology drug development and takes a looks at:

  • Using adaptive design to limit patient exposure to ineffective treatments and increase the overall likelihood of success
  • Making the most of small and geographically dispersed patient populations
  • Dealing with limitations such as a lack of defined biomarkers and baseline standard-of-care therapies
  • Finding out what Dr. Colin Hayward, our chief medical officer, would be doing if he weren’t working in clinical development!

Where to find us: